Key facts
- This page summarizes Glenn S. Boehnlein's Form 4 filing for DEXCOM INC (DXCM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Sep 2026, 16:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
Footnote F2
Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.